CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS

Sinopharm offers to take China-TCM private in nearly $3 bln deal

Sinopharm, the parent of China-TCM, already holds a 32.46 per cent stake in China-TCM and has offered to pay HK$4.6 per share in cash to buyout the drugmaker.